Heart failure with reduced ejection fraction: a review

SP Murphy, NE Ibrahim, JL Januzzi - Jama, 2020 - jamanetwork.com
Importance Worldwide, the burden of heart failure has increased to an estimated 23 million
people, and approximately 50% of cases are HF with reduced ejection fraction (HFrEF) …

Diuretic Therapy for Patients With Heart Failure: JACC State-of-the-Art Review

GM Felker, DH Ellison, W Mullens, ZL Cox… - Journal of the American …, 2020 - jacc.org
Expansion of extracellular fluid volume is central to the pathophysiology of heart failure.
Increased extracellular fluid leads to elevated intracardiac filling pressures, resulting in a …

Role of kynurenine pathway in oxidative stress during neurodegenerative disorders

A Mor, A Tankiewicz-Kwedlo, A Krupa, D Pawlak - Cells, 2021 - mdpi.com
Neurodegenerative disorders are chronic and life-threatening conditions negatively affecting
the quality of patients' lives. They often have a genetic background, but oxidative stress and …

Boundaries and integration between microbiota, the nervous system, and immunity

AJ Macpherson, V Pachnis, M Prinz - Immunity, 2023 - cell.com
The enteric nervous system is largely autonomous, and the central nervous system is
compartmentalized behind the blood-brain barrier. Yet the intestinal microbiota shapes gut …

Role of the microbiome in gut-heart-kidney cross talk

G Glorieux, SK Nigam, R Vanholder… - Circulation …, 2023 - Am Heart Assoc
Homeostasis is a prerequisite for health. When homeostasis becomes disrupted, dysfunction
occurs. This is especially the case for the gut microbiota, which under normal conditions …

Clinical pharmacology in diuretic use

DH Ellison - Clinical Journal of the American Society of …, 2019 - journals.lww.com
Diuretics are among the most commonly prescribed drugs and, although effective, they are
often used to treat patients at substantial risk for complications, making it especially …

The SLC22 transporter family: a paradigm for the impact of drug transporters on metabolic pathways, signaling, and disease

SK Nigam - Annual review of pharmacology and toxicology, 2018 - annualreviews.org
The SLC22 transporter family consists of more than two dozen members, which are
expressed in the kidney, the liver, and other tissues. Evolutionary analysis indicates that …

[HTML][HTML] Hyperuricemia as a trigger of immune response in hypertension and chronic kidney disease

C Ponticelli, MA Podestà, G Moroni - Kidney international, 2020 - Elsevier
Accumulating evidence indicates that asymptomatic hyperuricemia is involved in the
development of hypertension and chronic kidney disease. A 2-hit model has been proposed …

Physiologically‐based pharmacokinetic modeling in renal and hepatic impairment populations: a pharmaceutical industry perspective

T Heimbach, Y Chen, J Chen, V Dixit… - Clinical …, 2021 - Wiley Online Library
The predictive performance of physiologically‐based pharmacokinetics (PBPK) models for
pharmacokinetics (PK) in renal impairment (RI) and hepatic impairment (HI) populations was …

Chronic kidney disease and gut microbiota

SA Khiabani, M Asgharzadeh, HS Kafil - Heliyon, 2023 - cell.com
Chronic kidney disease (CKD) refers to a range of various pathophysiological processes
correlated with abnormal renal function and a progressive loss in GFR. Just as dysbiosis …